[1] Marcus S.L., Photodynamic therapy of human cancer, Proceedings of the IEEE, 1992; 80 (6): 869-889.
[2] Ackroyd R., Kelty C., Brown N., and Reed M., The history of photodetection and photodynamic therapy, Photochem. Photobiol., 2001; 74: 656-669.
[3] Brown S.B., Brown E.A. and Walker I., The present and future role of photodynamic therapy in cancer treatment, Lancet Oncol., 2004; 5: 497-508.
[4] Mitton D., and Ackroyd R., A brief overview of photodynamic therapy in Europe, Photodiagnosis and Photodynamic Therapy, 2008; 5: 103-111.
[5] Dougherty T.J., Gomer C.J., and Jori G., Photodynamic therapy, Journal of the National Cancer Institute, 1998; 90(12): 889-905.
[6] Wilson B.C., Patterson M.S., The physics, biophysics and technology of photodynamic therapy, Phys. Med. Biol., 2008; 53: R61–R109.
[7] Amelink A., van der Ploeg van den Heuvel A., de Wolf W.J., Robinson D.J., Sterenborg H.J.C.M., Monitoring PDT by means of superficial reflectance spectroscopy, J. Photochem. Photobiol. B: Biol., 2005; 79: 243-251.
[8] Zhou X.D., Pogue B.W., Chen B., Demidenko E., Joshi R., Hoopes J., Hasan T., Pretreatment photosensitizer dosimetry reduces variation in tumor response, Int. J. Radiat. Oncol. Biol. Phys., 2006; 64: 1211-1220.
[9] Liu B., Farrell T.J., and Patterson M.S., A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen, Phys Med Biol, 2010; 55(19): 5913-5932.
[10] Kruijt B., de Bruijn H.S., van der Ploeg den Heuvel A., de Bruin R.W.F., Sterenborg H.J.C.M., Amelink A., and Robinson D.J., Monitoring ALA-induced PpIX photodynamic therapy in the rat esophagus using fluorescence and reflectance spectroscopy, Photochem. Photo biol., 2008; 84: 1515-1527.
[11] Zhu T.C., Finlay J.C., Hahn S.M., Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy, J. Photochem. Photobiol., 2005; 79: 231-241.
[12] Robinson D.J., Bruijn H.S., van der Veen N., Stringer M.R., Brown S.B., Star W.M., Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect, Photochem. Photobiol. 1998; 67: 140–149.
[13] Peng Q., Warloe T., Berg K., Moan J., Kongshaug M., Giercksky K.E., Nesland J.M., 5-Aminolevulinic acid-based photodynamic therapy, clinical research and future challenges. Cancer, 1997; 79: 2282-2308.
[14] Wilson B.C., Patterson M.S., Lilge L., Implicit and explicit dosimetry in photodynamic therapy: a new paradigm, Lasers Med. Sci., 1997; 12: 182-199.
[15] Foster T.H., Gao L., Dosimetry in photodynamic therapy-oxygen and the critical importance of capillary density, Radiat. Res., 1992; 130: 379-383.
[16] Aalders M.C.G., van der Vange N., Star W.M., Sterenborg H.J.C.M., A mathematical evaluation of dose-dependent PpIX fluorescence kinetics in vivo, Photochemistry and Photobiology., 2001; 74(2): 311-317.
[17] Jacques S.L., The mathematics of PDT dosimetry for cancer treatment. http://omlc.ogi.edu/pdf/PDTmath/ index. html,1998.
[18] Svaasand L.O., Dosimetry model for photodynamic therapy with topically administered photosensitizers, Lasers in Surgery and Medicine., 1996; 18: 139-149.
[19] Mang T.S., Dosimetric concepts for PDT, Photodiagnosis and Photodynamic Therapy, 2008; 5(3); 217-223.
[20] Dysart J.S. and Patterson M.S., Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro, Phys. Med. Biol., 2005; 50: 2597–2616.
[21] Dysart J.S. and Patterson M.S., Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions, Photochem. Photobiol. Sci., 2006; 5:73–81.
[22] Dysart J.S., Singh G., Patterson M.S., Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells, Photochem. Photobiol., 2005; 81:196–205.
[23] Sheng C., Hoopes P.J., Hasan T., Pogue B.W., Photobleaching-based dosimetry predicts deposited dose in ALA-PpIX PDT of rodent esophagus, Photochemistry and Photobiology., 2007; 83: 738-748.
[24] Theodossiou T., MacRobert A.J., Comparison of the photodynamic effet of exogenous photoprotoporphyrin and protoporphyrin IX on PAM 212 murin keratinocytes, Photochem. Photobiol., 2002; 76: 530-537.
[25] Stringer M.R., Kelty C.J., Ackroyd R., Brown S.B., Light dosimetry measurements during ALA-PDT of Barrett's oesophagus, Photodiagnosis and Photodynamic Therapy, 2006; 3: 19-26.
[26] Juzenas P., Juzeniene A., Stakland S., Iani V., Moan J., Photosensitizing effect of protoporphyrin IX in pigmented melanoma of mice, Biochem. Biophys. Res. Cummun., 2002; 297(3): 468-72.
[27] Peng Q., Moan J., Warloe T., Nesland J.M., Rimington C., Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int. J. Cancer, 1992; 52: 433-443.
[28] Dolmans D.E., Fukumura D., Jain R.K., Photodynamic therapy for cancer, Nat. Rev. Cancer, 2003; 3:380-387.
[29] Reneau D.D., Bruley D.F., Knisely M.H., A digital simulation of transient oxygen transport in capillary-tissue systems (cerebral grey matter): development of a numerical method for solution of transport equations describing coupled convection-diffusion systems, AIChE J., 1969; 15: 916-925.
[30] Reneau D.D., Bruley D.F., Knisely M.H., A computer simulation for prediction of oxygen limitations in cerebral gray matter. JAAMI J., 1970; 4 (6): 211-223.
[31] Lagerlund T.D. and Low P.A., Axial diffusion and Michaelis-Menten kinetics in oxygen delivery in rat peripheral-nerve, Am. J. of Physiol., 1991; 260(2): R430-R440.
[32] Georgakoudi I., Nichols M.G., Foster T.H., The mechanism of photofrin photobleaching and its consequences for photodynamic Dosimetry, Photochem. Photobiol., 1997; 65: 135-144.
[33] Wang K.K.H., Mitra S., Foster T.H., Photodynamic dose does not correlate with lomg-term tumor response to mTHPC-PDT performed at several drug-light intervals, Med. Phys., 2008; 35(8): 3518-3526.
[34] Lagerlund T.D. and Low P.A., Mathematical-modeling of time-dependent oxygen-transport in rat peripheral-nerve. Comput. Biol. Med., 1993; 23: 29-47.
[35] Pandey S.K., Multi modality agents for tumor imaging (PET, fluorescence) and photodynamic therapy, A possible see and treat approach, Med.Chem., 2005; 48: 6286–6295.
[36] Wilson B.C., Weersink R.A., and Lilge L., Fluorescence in photodynamic therapy dosimetry, Handbook of Biomedical Fluorescence, Chapter15, New York, Basel, 2003.
[37] Farrell T.J., Patterson M.S., Hayward J.E., and Wilson B.C., A CCD and neural network based instrument for the non-invasive determination of tissue optical properties in-vivo, SPIE Proc., 1994; 2135:117–128.